Singular Genomics Launches G4X™ in the U.S., Delivering Industry-Leading Throughput for In Situ Multiomics, Targets Translational and Clinical Applications

SAN DIEGO, Feb. 18, 2026 /PRNewswire/ — Singular Genomics, a company delivering high-throughput spatial technologies to advance precision medicine, today announced the commercial launch and U.S. availability of G4X. The launch marks a major milestone in making large-scale spatial…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks